249 related articles for article (PubMed ID: 19491715)
1. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
Liu Q; Zhao S; Yan C; Lu M; Jiang S; Zhang Y; Li S; Liu Y; Yang M; He Z
Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715
[TBL] [Abstract][Full Text] [Related]
2. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging and comparison with single-photon emission computed tomography.
Wang YN; Jin ZY; Zhang ZH; Kong LY; Chen LB; Zhou L; Sun HY; Zhang H; Miao Q
Chin Med Sci J; 2006 Dec; 21(4):239-44. PubMed ID: 17249199
[TBL] [Abstract][Full Text] [Related]
3. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
[TBL] [Abstract][Full Text] [Related]
4. [Identification of viable myocardium delayed enhancement magnetic resonance imaging and 99Tcm-sestamibi or 18F-fluorodeoxyglucose single photon emission computed tomography].
Zhao SH; Yan CW; Yang MF; Lu MJ; Jiang SL; Li SG; Zhang Y; Liu Q; Liu YQ; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1072-6. PubMed ID: 17274892
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography.
Dangas G; Machac J; Goldman ME; Sharma SK; Shao JH; Cohen AM; Meraj P; Feldman D; Ambrose JA
Coron Artery Dis; 2000 Jul; 11(5):409-14. PubMed ID: 10895407
[TBL] [Abstract][Full Text] [Related]
7. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
Kühl HP; Beek AM; van der Weerdt AP; Hofman MB; Visser CA; Lammertsma AA; Heussen N; Visser FC; van Rossum AC
J Am Coll Cardiol; 2003 Apr; 41(8):1341-8. PubMed ID: 12706930
[TBL] [Abstract][Full Text] [Related]
8. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
[TBL] [Abstract][Full Text] [Related]
11. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
[TBL] [Abstract][Full Text] [Related]
12. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
[TBL] [Abstract][Full Text] [Related]
13. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
[TBL] [Abstract][Full Text] [Related]
14. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
[TBL] [Abstract][Full Text] [Related]
15. Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.
Nkoulou R; Pazhenkottil AP; Buechel RR; Husmann L; Valenta I; Herzog BA; Wolfrum M; Ghadri JR; Kaufmann PA
Int J Cardiovasc Imaging; 2011 Jul; 27(6):913-21. PubMed ID: 20931288
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
17. Functional evaluation of myocardial viability by 99mTc tetrofosmin gated SPECT--a quantitative comparison with 18F fluorodeoxyglucose positron emission CT (18F FDG PET).
Kuwabara Y; Watanabe S; Nakaya J; Fujiwara M; Hasegawa R; Matsuno K; Kuroda T; Mikami Y; Fujii K; Himi T; Masuda Y
Ann Nucl Med; 1999 Jun; 13(3):135-40. PubMed ID: 10435372
[TBL] [Abstract][Full Text] [Related]
18. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
[TBL] [Abstract][Full Text] [Related]
20. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.
Roes SD; Kaandorp TA; Marsan NA; Westenberg JJ; Dibbets-Schneider P; Stokkel MP; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):594-601. PubMed ID: 19050879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
